Walgreens takes action due to Washington state reimb cuts

30 March 2009

As a result of extreme reimbursement cuts in the US State of Washington Medicaid program, drug store chain Walgreens says it will withdraw 44 of  its pharmacies from the state's Medicaid program as of May 1. These  represent more than 60% of the company's total Medicaid business in the  state and are found in both large and small communities. Walgreens  operates 111 pharmacies throughout Washington.

Under a new Medicaid reimbursement rule set to take effect on April 1,  the State of Washington will significantly reduce the price it will pay  for brand name medications, severely impacting the economic viability of  doing business in Washington.

Kermit Crawford, Walgreens senior vice president of pharmacy, said: "we  have made the decision to stop filling Medicaid prescriptions in these  pharmacies after long and careful deliberations. Walgreens is the market  leader in Washington and provides cost-effective pharmacy service  across the state. We have thousands of loyal patients who appreciate and  trust our pharmacists, and we are absolutely committed to patient care."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight